loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2007_017___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Urquima S.A. Grupo Uriach

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 URQUIMA S.A. Palau-solità i Plegamans ES (1)

    filter

    01 Glimepiride (1)

    filter

    01 Spain (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    URQUIMA S.A. Palau-solità i Plegam...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Glimepiride

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2007-017 - Rev 03
    Valid
    Chemical
    2022-06-10
    2223
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2007-017 - Rev 03 of Urquima S.a. Palau-solità I Plegamans Es

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2007-017 - Rev 03 of Urquima S.a. Palau-solità I Plegamans Es 1

    20

    Urquima S.a. Palau-solità I Plegamans Es, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Glimepiride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-017 - Rev 03

    This Chemical Type CEP, issued on June 10, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2223 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY